CMS, FDA, HRSA Developing Rx-Price Proposals

CMS, FDA and the Health Resources and Services Administration are developing recommendations for lowering drug prices, HHS Secretary Tom Price said on June 8, and providers worry the Part B drug price demonstration proposal might still be on the table, despite that the Obama administration deserted the idea in the face of opposition from drug makers, patients and cancer doctors. "We've charged HRSA and FDA and CMS with coming up with specific proposals to make certain we can provide the...